Data from public SEC 13F & STOCK Act filings, delayed up to ~45 days, partial holdings only — for research, not investment advice.
ACAD
ACADIA PHARMACEUTICALS INCData as of 2026 Q1 (03-31) · 13F snapshot
Summary
ACADIA PHARMACEUTICALS INC (ACAD) is held by 8 tracked hedge-fund managers, a combined reported value of ~$142.75M; the largest are Steven Cohen, Renaissance Technologies, Izzy Englander. This quarter: 4 added, 2 trimmed. 3 members of Congress have disclosed STOCK Act trades. Data as of 2026 Q1, from public SEC 13F filings, delayed up to ~45 days.
Attention · HighThis quarter · Heating up
Gurus holding8
Congress trades3
Price$21.09vs quarter-end-5.26%
Sectors0
This quarter's moves
Top holderSteven CohenNew0
Added4
Trimmed / sold2
Value $2.73M— of portfolio130,9002023 Q3
Value $1.78M0.1% of portfolio74,4002023 Q2
Value $948.5K— of portfolio51,3002024 Q1
Value $445.2K— of portfolio20,0002026 Q1
Value $353.9K— of portfolio15,9002026 Q1
Value $305.0K— of portfolio13,7002026 Q1
Value $305.0K— of portfolio13,7002026 Q1
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Izzy EnglanderPUT | $2.73M | — | — |
| Stanley Druckenmiller | $1.78M | 0.1% | Hold |
| Izzy EnglanderCALL | $948.5K | — | — |
| Ken GriffinCALL | $445.2K | — | — |
| Ken GriffinPUT | $353.9K | — | — |
| Steven CohenCALL | $305.0K | — | — |
| Steven CohenPUT | $305.0K | — | — |